Paul Tudor Jones's PHAT Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 38,225 shares of Phathom Pharmaceuticals, Inc. (PHAT) worth $424,680, representing 0.00% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 6 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in PHAT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 34,090 shares. Largest reduction occurred in Q1 2025, reducing 34,049 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Phathom Pharmaceuticals (PHAT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Phathom Pharmaceuticals (PHAT) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +9,671 | Add 33.87% | 38,225 | $11.11 |
| Q4 2025 | -5,536 | Reduce 16.24% | 28,554 | $16.59 |
| Q3 2025 | +34,090 | New Buy | 34,090 | $11.77 |
| Q1 2025 | -34,049 | Sold Out | 0 | $0.00 |
| Q4 2024 | -2,334 | Reduce 6.42% | 34,049 | $8.12 |
| Q3 2024 | +36,383 | New Buy | 36,383 | $18.08 |
Paul Tudor Jones's Phathom Pharmaceuticals Investment FAQs
Paul Tudor Jones first purchased Phathom Pharmaceuticals, Inc. (PHAT) in Q3 2024, acquiring 36,383 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Phathom Pharmaceuticals, Inc. (PHAT) for 6 quarters since Q3 2024.
Paul Tudor Jones's largest addition to Phathom Pharmaceuticals, Inc. (PHAT) was in Q3 2024, adding 36,383 shares worth $657,805.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 38,225 shares of Phathom Pharmaceuticals, Inc. (PHAT), valued at approximately $424,680.
As of the Q1 2026 filing, Phathom Pharmaceuticals, Inc. (PHAT) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Phathom Pharmaceuticals, Inc. (PHAT) was 38,225 shares, as reported at the end of Q1 2026.